肝原性糖尿病的临床分析  

The Clinical Analysis of Hepatogenous Diabetes

作　　者：高桂花[1] 张孝 王伟[1] 李晓萍[1] 

机构地区：[1]内蒙古医科大学第三附属医院感染疾病科,内蒙古包头014010 [2]包头市包钢三医院介入科

出　　处：《疾病监测与控制》2015年第2期90-90,89,共2页Journal of Diseases Monitor and Control

摘　　要：目的总结肝原性糖尿病治疗经验。方法回顾性分析近5年我院125例肝原性糖尿病患者临床资料。结果积极保肝、胰岛素控制血糖治疗效果显著。糖尿病缺乏临床典型症状,随肝功能好转而好转。结论慢性肝病并发糖尿病发生率高,临床表现不典型,早期诊断具有临床意义;积极保肝、胰岛素控制血糖在临床取得显著疗效。Objective Summarize the treatment experience of hepatogenous diabetes. Methods Retrospectively analyze the clinical dams of 125 cases of patients with hepatogenous diabetes in recent 5 years. Results At the same time of actively protecting liver, the therapy effect of controlling blood sugar by insulin is remarkable. Diabetes lack typical clinical symptoms, and the situation of patients improve along with the improvement of liver function. Conclusion The occurrence rate of Chronic liver disease complicated with diabetes is high, and the clinical manifestation is not typical, early diagnosis have clinical significance. Positively protecting liver and controlling blood sugar by insulin have significant clinical effect.

关 键 词：病毒性肝炎 肝原性糖尿病 胰岛素 

分 类 号：R587.1[医药卫生—内分泌]